JP Morgan Chase’s Magellan Health Services, Inc. MGLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-282,754
| Closed | -$26.9M | – | 7334 |
|
|
2021
Q4 | $26.9M | Buy |
282,754
+233,567
| +475% | +$22.1M | ﹤0.01% | 1579 |
|
|
2021
Q3 | $4.65M | Sell |
49,187
-170,267
| -78% | -$16.1M | ﹤0.01% | 3090 |
|
|
2021
Q2 | $20.7M | Sell |
219,454
-23,272
| -10% | -$2.19M | ﹤0.01% | 1816 |
|
|
2021
Q1 | $22.6M | Sell |
242,726
-73,765
| -23% | -$6.91M | ﹤0.01% | 1655 |
|
|
2020
Q4 | $26.2M | Sell |
316,491
-135,010
| -30% | -$10.7M | ﹤0.01% | 1427 |
|
|
2020
Q3 | $33.7M | Buy |
451,501
+45,440
| +11% | +$3.37M | 0.01% | 1181 |
|
|
2020
Q2 | $29.6M | Sell |
406,061
-656,080
| -62% | -$42M | 0.01% | 1131 |
|
|
2020
Q1 | $51.1M | Buy |
1,062,141
+237,030
| +29% | +$15.2M | 0.01% | 793 |
|
|
2019
Q4 | $64.6M | Buy |
825,111
+85,217
| +12% | +$5.99M | 0.01% | 838 |
|
|
2019
Q3 | $45.9M | Buy |
739,894
+239,784
| +48% | +$16M | 0.01% | 994 |
|
|
2019
Q2 | $35.9M | Buy |
500,110
+308,417
| +161% | +$20.7M | 0.01% | 1172 |
|
|
2019
Q1 | $12.6M | Buy |
191,693
+29,412
| +18% | +$1.89M | ﹤0.01% | 1852 |
|
|
2018
Q4 | $9.23M | Sell |
162,281
-393,519
| -71% | -$24.3M | ﹤0.01% | 2082 |
|
|
2018
Q3 | $40M | Sell |
555,800
-123,089
| -18% | -$9.9M | 0.01% | 1150 |
|
|
2018
Q2 | $65.1M | Sell |
678,889
-14,348
| -2% | -$1.38M | 0.01% | 846 |
|
|
2018
Q1 | $74.2M | Buy |
693,237
+2,301
| +0.3% | +$231K | 0.02% | 757 |
|
|
2017
Q4 | $66.7M | Buy |
690,936
+50,741
| +8% | +$4.49M | 0.01% | 844 |
|
|
2017
Q3 | $54.9M | Sell |
640,195
-87,400
| -12% | -$6.89M | 0.01% | 878 |
|
|
2017
Q2 | $53M | Sell |
727,595
-165,677
| -19% | -$11.6M | 0.01% | 879 |
|
|
2017
Q1 | $61.7M | Buy |
893,272
+43,827
| +5% | +$3.2M | 0.01% | 839 |
|
|
2016
Q4 | $63.9M | Buy |
849,445
+96,701
| +13% | +$6.19M | 0.02% | 773 |
|
|
2016
Q3 | $40.4M | Buy |
752,744
+103,451
| +16% | +$6.24M | 0.01% | 935 |
|
|
2016
Q2 | $42.7M | Sell |
649,293
-63,941
| -9% | -$4.31M | 0.01% | 920 |
|
|
2016
Q1 | $48.5M | Sell |
713,234
-22,072
| -3% | -$1.33M | 0.01% | 823 |
|
|
2015
Q4 | $45.3M | Buy |
735,306
+99,205
| +16% | +$5.33M | 0.01% | 848 |
|
|
2015
Q3 | $35.3M | Sell |
636,101
-120
| -0% | -$7.25K | 0.01% | 948 |
|
|
2015
Q2 | $44.6M | Sell |
636,221
-20,629
| -3% | -$1.4M | 0.01% | 940 |
|
|
2015
Q1 | $46.5M | Buy |
656,850
+24,277
| +4% | +$1.53M | 0.01% | 935 |
|
|
2014
Q4 | $38M | Sell |
632,573
-56,482
| -8% | -$3.34M | 0.01% | 1079 |
|
|
2014
Q3 | $37.7M | Sell |
689,055
-116,124
| -14% | -$6.66M | 0.01% | 1060 |
|
|
2014
Q2 | $50.1M | Sell |
805,179
-107,779
| -12% | -$6.33M | 0.01% | 852 |
|
|
2014
Q1 | $54.2M | Buy |
912,958
+20,286
| +2% | +$1.21M | 0.01% | 769 |
|
|
2013
Q4 | $53.5M | Buy |
892,672
+687,615
| +335% | +$41.1M | 0.02% | 775 |
|
|
2013
Q3 | $12.3M | Sell |
205,057
-44,480
| -18% | -$2.58M | ﹤0.01% | 1633 |
|
|
2013
Q2 | $14M | Buy |
+249,537
| New | +$13.1M | ﹤0.01% | 1461 |
|
JP Morgan Chase's MGLN Position: Q1 2022 in Review
JP Morgan Chase sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 282,754 shares — an estimated $26.9M sold.
JP Morgan Chase first reported a position in MGLN in Q2 2013 and held it in 35 quarters. The position peaked at $74.2M in Q1 2018. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.
- JP Morgan Chase reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
- JP Morgan Chase sold 282,754 Magellan Health Services, Inc. shares in Q1 2022, an estimated $26.9M.
- JP Morgan Chase first reported a position in Magellan Health Services, Inc. in Q2 2013 and held it in 35 quarters.
- JP Morgan Chase's Magellan Health Services, Inc. position peaked at $74.2M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.